#Dexcool coolant concentrate skin#

Cardiac failure and pulmonary edema may develop.

Ingestion: May cause abdominal discomfort or pain, nausea, vomiting, dizziness, drowsiness, malaise, blurring of vision, irritability, back pain, decrease in urine output, kidney failure, and central nervous system effects, including irregular eye movements, convulsions and coma. High vapor concentrations caused, for example, by heating the material in an enclosed and poorly ventilated workplace, may produce nausea, vomiting, headache, dizziness and irregular eye movement. Inhalation: May cause irritation of the nose and throat with headache, particularly from mists.

#Dexcool coolant concentrate skin#

Skin Contact: No evidence of adverse effects from available information. Serious corneal injury is not anticipated. IF exposed or concerned: Get medical advice.ĭispose of contents and container in accordance with local and national regulations.Įye Contact: Liquid, vapors or mist may cause discomfort in the eye with persistent conjunctivitis, seen as slight excess redness or conjunctiva. IF SWALLOWED: Call a POISON CENTER or physician if you feel unwell. Wear protective gloves and eye protection. Do not eat, drink, or smoke when using this product. Wash exposed skin thoroughly after handling. Do not handle until all safety precautions have been read and understood.ĭo not breathe mist or vapors. May cause damage to kidneys through prolonged or repeated exposure. Measure of Alkalinity/Acidity of substance or preparation where a level of 7 is considered as neutral. HMIS is the Hazardous Materials Identification System developed by the American Coatings Association and indicates the levels (“1” to “4”) of Health Hazard, Flammability Hazard and Physical Hazard associated with a specific product.HMIS RATING Products are not tested and manufacturer's information presented here is not evaluated by DeLima Associates.ĭate that the Safety Data Sheet (SDS) was issued by manufacturer of a specific product.SDS DATE : Ingredients and Health Effects Information are taken from the manufacturer's product label and/or the Safety Data Sheet (SDS). Hexanoic acid, 2-ethyl-, sodium salt (1:1)

Identified, on a case-by-case basis, from scientific evidence as causing probable serious effects to human health or the environment of an equivalent level of concern as those above (e.g. Persistent, Bioaccumulative and Toxic (PBT) or very Persistent and very Bioaccumulative (vPvB) according to the criteria in Annex XIII of the REACH Regulation, orģ. Carcinogenic, Mutagenic or toxic to Reproduction (CMR), meeting the criteria for classification in category 1 or 2 in accordance with Directive 67/548/EEC or in category 1a or 1b in accordance with EC No 1272/2008This directive was recently replaced by the new EU regulation (EC) No 1272/2008.Ģ. SVHC are defined in Article 57 of Regulation (EC) No 1907/2006 (“the REACH Regulation”) and include substances which are:ġ. SVHC is a substance (identified by the European Chemicals Agency) that may have serious and often irreversible effects on human health and the environment.